Experience with radium-223 as a systemic treatment for patients (pts) with castration-resistant prostate cancer (CRPC) out of a clinical trial in Spain

Autores: Grande, E.; Pinto, A.; Duran, I.; Lopez Criado, P.; Suarez, C.; Gonzalez Larriba, J. L.; Sánchez Lorenzo, María Luisa; Maroto, P.; Lainez, N.; Gonzalez del Alba, A.; Saez, M. I.; Alonso Gordoa, T.; Perez Valderrama, B.; Puente, J.; Morales, R.; Esteban, E.; Manneh, R.; Benedetti, J.; Carles Galceran, J.; Castellano, D.